Phibro Animal Health (NASDAQ:PAHC) Stock Price Crosses Above 50-Day Moving Average of $16.39

Phibro Animal Health Co. (NASDAQ:PAHCGet Free Report)’s share price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $16.39 and traded as high as $17.66. Phibro Animal Health shares last traded at $17.48, with a volume of 71,982 shares trading hands.

Wall Street Analysts Forecast Growth

Several research firms have commented on PAHC. StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Tuesday, April 9th. Barclays increased their target price on Phibro Animal Health from $10.00 to $13.00 and gave the company an “underweight” rating in a research report on Friday, May 10th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and an average price target of $14.75.

Check Out Our Latest Stock Analysis on PAHC

Phibro Animal Health Stock Up 1.5 %

The company has a debt-to-equity ratio of 1.69, a current ratio of 3.16 and a quick ratio of 1.67. The company has a market capitalization of $718.47 million, a P/E ratio of 55.44, a P/E/G ratio of 5.79 and a beta of 0.59. The stock has a 50-day moving average price of $16.57 and a 200-day moving average price of $13.55.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last released its earnings results on Wednesday, May 8th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. Phibro Animal Health had a return on equity of 17.11% and a net margin of 1.32%. The business had revenue of $263.20 million during the quarter, compared to analysts’ expectations of $251.82 million. On average, research analysts predict that Phibro Animal Health Co. will post 1.13 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 5th will be paid a $0.12 dividend. The ex-dividend date is Wednesday, June 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.71%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 150.00%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Barclays PLC lifted its holdings in Phibro Animal Health by 59.8% during the third quarter. Barclays PLC now owns 35,638 shares of the company’s stock worth $456,000 after acquiring an additional 13,332 shares during the period. Trexquant Investment LP raised its stake in shares of Phibro Animal Health by 143.6% in the third quarter. Trexquant Investment LP now owns 35,872 shares of the company’s stock valued at $458,000 after buying an additional 21,147 shares during the period. BNP Paribas Financial Markets raised its stake in shares of Phibro Animal Health by 290.2% in the fourth quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company’s stock valued at $849,000 after buying an additional 54,506 shares during the period. China Universal Asset Management Co. Ltd. raised its stake in shares of Phibro Animal Health by 358.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock valued at $27,000 after buying an additional 1,843 shares during the period. Finally, Louisiana State Employees Retirement System bought a new stake in shares of Phibro Animal Health in the fourth quarter valued at $118,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Further Reading

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.